Caspase-14 expression impairs retinal pigment epithelium barrier function: Potential role in diabetic macular edema

Selina Beasley, Mohamed El-Sherbiny, Sylvia Megyerdi, Sally El-Shafey, Karishma Choksi, Ismail Kaddour-Djebbar, Nader Sheibani, Stephen Hsu, Mohamed Al-Shabrawey

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We recently showed that caspase-14 is a novel molecule in retina with potential role in accelerated vascular cell death during diabetic retinopathy (DR). Here, we evaluated whether caspase-14 is implicated in retinal pigment epithelial cells (RPE) dysfunction under hyperglycemia. The impact of high glucose (HG, 30 mM D-glucose) on caspase-14 expression in human RPE (ARPE-19) cells was tested, which showed significant increase in caspase-14 expression compared with normal glucose (5 mM D-glucose + 25 mM L-glucose). We also evaluated the impact of modulating caspase-14 expression on RPE cells barrier function, phagocytosis, and activation of other caspases using ARPE-19 cells transfected with caspase-14 plasmid or caspase-14 siRNA. We used FITC-dextran flux assay and electric cell substrate impedance sensing (ECIS) to test the changes in RPE cell barrier function. Similar to HG, caspase-14 expression in ARPE-19 cells increased FITC-dextran leakage through the confluent monolayer and decreased the transcellular electrical resistance (TER). These effects of HG were prevented by caspase-14 knockdown. Furthermore, caspase-14 knockdown prevented the HG-induced activation of caspase-1 and caspase-9, the only activated caspases by HG. Phagocytic activity was unaffected by caspase-14 expression. Our results suggest that caspase-14 contributes to RPE cell barrier disruption under hyperglycemic conditions and thus plays a role in the development of diabetic macular edema.

Original languageEnglish (US)
Article number417986
JournalBioMed Research International
Volume2014
DOIs
StatePublished - 2014

Fingerprint

Caspase 14
Retinal Pigments
Macular Edema
Retinal Pigment Epithelium
Epithelial Cells
Glucose
Caspases
Electric Impedance
Chemical activation
Electric batteries
Caspase 1
Acoustic impedance
Caspase 9

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Caspase-14 expression impairs retinal pigment epithelium barrier function : Potential role in diabetic macular edema. / Beasley, Selina; El-Sherbiny, Mohamed; Megyerdi, Sylvia; El-Shafey, Sally; Choksi, Karishma; Kaddour-Djebbar, Ismail; Sheibani, Nader; Hsu, Stephen; Al-Shabrawey, Mohamed.

In: BioMed Research International, Vol. 2014, 417986, 2014.

Research output: Contribution to journalArticle

Beasley, Selina ; El-Sherbiny, Mohamed ; Megyerdi, Sylvia ; El-Shafey, Sally ; Choksi, Karishma ; Kaddour-Djebbar, Ismail ; Sheibani, Nader ; Hsu, Stephen ; Al-Shabrawey, Mohamed. / Caspase-14 expression impairs retinal pigment epithelium barrier function : Potential role in diabetic macular edema. In: BioMed Research International. 2014 ; Vol. 2014.
@article{f43bb37472d74b29b233b0a3b081fee1,
title = "Caspase-14 expression impairs retinal pigment epithelium barrier function: Potential role in diabetic macular edema",
abstract = "We recently showed that caspase-14 is a novel molecule in retina with potential role in accelerated vascular cell death during diabetic retinopathy (DR). Here, we evaluated whether caspase-14 is implicated in retinal pigment epithelial cells (RPE) dysfunction under hyperglycemia. The impact of high glucose (HG, 30 mM D-glucose) on caspase-14 expression in human RPE (ARPE-19) cells was tested, which showed significant increase in caspase-14 expression compared with normal glucose (5 mM D-glucose + 25 mM L-glucose). We also evaluated the impact of modulating caspase-14 expression on RPE cells barrier function, phagocytosis, and activation of other caspases using ARPE-19 cells transfected with caspase-14 plasmid or caspase-14 siRNA. We used FITC-dextran flux assay and electric cell substrate impedance sensing (ECIS) to test the changes in RPE cell barrier function. Similar to HG, caspase-14 expression in ARPE-19 cells increased FITC-dextran leakage through the confluent monolayer and decreased the transcellular electrical resistance (TER). These effects of HG were prevented by caspase-14 knockdown. Furthermore, caspase-14 knockdown prevented the HG-induced activation of caspase-1 and caspase-9, the only activated caspases by HG. Phagocytic activity was unaffected by caspase-14 expression. Our results suggest that caspase-14 contributes to RPE cell barrier disruption under hyperglycemic conditions and thus plays a role in the development of diabetic macular edema.",
author = "Selina Beasley and Mohamed El-Sherbiny and Sylvia Megyerdi and Sally El-Shafey and Karishma Choksi and Ismail Kaddour-Djebbar and Nader Sheibani and Stephen Hsu and Mohamed Al-Shabrawey",
year = "2014",
doi = "10.1155/2014/417986",
language = "English (US)",
volume = "2014",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Caspase-14 expression impairs retinal pigment epithelium barrier function

T2 - Potential role in diabetic macular edema

AU - Beasley, Selina

AU - El-Sherbiny, Mohamed

AU - Megyerdi, Sylvia

AU - El-Shafey, Sally

AU - Choksi, Karishma

AU - Kaddour-Djebbar, Ismail

AU - Sheibani, Nader

AU - Hsu, Stephen

AU - Al-Shabrawey, Mohamed

PY - 2014

Y1 - 2014

N2 - We recently showed that caspase-14 is a novel molecule in retina with potential role in accelerated vascular cell death during diabetic retinopathy (DR). Here, we evaluated whether caspase-14 is implicated in retinal pigment epithelial cells (RPE) dysfunction under hyperglycemia. The impact of high glucose (HG, 30 mM D-glucose) on caspase-14 expression in human RPE (ARPE-19) cells was tested, which showed significant increase in caspase-14 expression compared with normal glucose (5 mM D-glucose + 25 mM L-glucose). We also evaluated the impact of modulating caspase-14 expression on RPE cells barrier function, phagocytosis, and activation of other caspases using ARPE-19 cells transfected with caspase-14 plasmid or caspase-14 siRNA. We used FITC-dextran flux assay and electric cell substrate impedance sensing (ECIS) to test the changes in RPE cell barrier function. Similar to HG, caspase-14 expression in ARPE-19 cells increased FITC-dextran leakage through the confluent monolayer and decreased the transcellular electrical resistance (TER). These effects of HG were prevented by caspase-14 knockdown. Furthermore, caspase-14 knockdown prevented the HG-induced activation of caspase-1 and caspase-9, the only activated caspases by HG. Phagocytic activity was unaffected by caspase-14 expression. Our results suggest that caspase-14 contributes to RPE cell barrier disruption under hyperglycemic conditions and thus plays a role in the development of diabetic macular edema.

AB - We recently showed that caspase-14 is a novel molecule in retina with potential role in accelerated vascular cell death during diabetic retinopathy (DR). Here, we evaluated whether caspase-14 is implicated in retinal pigment epithelial cells (RPE) dysfunction under hyperglycemia. The impact of high glucose (HG, 30 mM D-glucose) on caspase-14 expression in human RPE (ARPE-19) cells was tested, which showed significant increase in caspase-14 expression compared with normal glucose (5 mM D-glucose + 25 mM L-glucose). We also evaluated the impact of modulating caspase-14 expression on RPE cells barrier function, phagocytosis, and activation of other caspases using ARPE-19 cells transfected with caspase-14 plasmid or caspase-14 siRNA. We used FITC-dextran flux assay and electric cell substrate impedance sensing (ECIS) to test the changes in RPE cell barrier function. Similar to HG, caspase-14 expression in ARPE-19 cells increased FITC-dextran leakage through the confluent monolayer and decreased the transcellular electrical resistance (TER). These effects of HG were prevented by caspase-14 knockdown. Furthermore, caspase-14 knockdown prevented the HG-induced activation of caspase-1 and caspase-9, the only activated caspases by HG. Phagocytic activity was unaffected by caspase-14 expression. Our results suggest that caspase-14 contributes to RPE cell barrier disruption under hyperglycemic conditions and thus plays a role in the development of diabetic macular edema.

UR - http://www.scopus.com/inward/record.url?scp=84904823385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904823385&partnerID=8YFLogxK

U2 - 10.1155/2014/417986

DO - 10.1155/2014/417986

M3 - Article

C2 - 25121097

AN - SCOPUS:84904823385

VL - 2014

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 417986

ER -